Evidence map›Paper›PMID 32905462›Full record

ArticleThe quarterly journal of economics2019

WHO PROFITS FROM PATENTS? RENT-SHARING AT INNOVATIVE FIRMS.

Patrick Kline, Neviana Petkova, Heidi Williams, Owen Zidar

Abstract read
In one paragraph

Article in The quarterly journal of economics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. REPRESENTATION AND EXTRAPOLATION: EVIDENCE FROM CLINICAL TRIALSThe quarterly journal of economics · 2024
    Article
  5. Article
  6. Article
  7. WHO PROFITS FROM PATENTS? RENT-SHARING AT INNOVATIVE FIRMS.The quarterly journal of economics · 2019
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Patrick KlineUniversity of California, Berkeley.
Neviana PetkovaU.S. Department of the Treasury.
Heidi WilliamsMassachusetts Institute of Technology.
Owen ZidarPrinceton University.

Funding

Empirical Studies of the Development and Diffusion of Medical TechnologiesU01AG046708 · NIA · NATIONAL BUREAU OF ECONOMIC RESEARCH · PI WILLIAMS, HEIDI LIE · 2013 to 2017
$1.4M
NIA NIH HHS U01 AG046708
6 · The paper itself

Abstract

This article analyzes how patent-induced shocks to labor productivity propagate into worker compensation using a new linkage of U.S. patent applications to U.S. business and worker tax records. We infer the causal effects of patent allowances by comparing firms whose patent applications were initially allowed to those whose patent applications were initially rejected. To identify patents that are ex ante valuable, we extrapolate the excess stock return estimates of Kogan et al. (2017) to the full set of accepted and rejected patent applications based on predetermined firm and patent application characteristics. An initial allowance of an ex ante valuable patent generates substantial increases in firm productivity and worker compensation. By contrast, initial allowances of lower ex ante value patents yield no detectable effects on firm outcomes. Patent allowances lead firms to increase employment, but entry wages and workforce composition are insensitive to patent decisions. On average, workers capture roughly 30 cents of every dollar of patent-induced surplus in higher earnings. This share is roughly twice as high among workers present since the year of application. These earnings effects are concentrated among men and workers in the top half of the earnings distribution and are paired with corresponding improvements in worker retention among these groups. We interpret these earnings responses as reflecting the capture of economic rents by senior workers, who are most costly for innovative firms to replace.

Indexed as

J01O3O34

Identifiers

PMID32905462
PMCPMC7470084

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.